eMedicine Specialties > Obstetrics and Gynecology > General Gynecology
Ovarian Cysts
Updated: Feb 2, 2010
Introduction
Background
An ovarian cyst is a sac filled with liquid or semi-liquid material arising in an ovary. The number of diagnoses of ovarian cysts has increased with the widespread implementation of regular physical examinations and ultrasound technology. The finding of an ovarian cyst causes considerable anxiety for women because of the fear of malignancy, but the vast majority of ovarian cysts are benign.
Pathophysiology
Each month, normally functioning ovaries develop small cysts called Graafian follicles.1 At mid cycle, a single dominant follicle up to about 2.8 cm in diameter releases a mature oocyte.
The ruptured follicle becomes the corpus luteum, which, at maturity, is a 1.5- to 2-cm structure with a cystic center. In the absence of fertilization of the oocyte, it undergoes progressive fibrosis and shrinkage. If fertilization occurs, the corpus luteum initially enlarges and then gradually decreases in size during pregnancy.
Ovarian cysts arising in the normal process of ovulation are called functional cysts and are always benign. They may be follicular and luteal, sometimes called theca-lutein cysts. These cysts can be stimulated by gonadotropins, including follicle-stimulating hormone (FSH) and human chorionic gonadotropin (hCG). A theca-lutein cyst is shown in the sonogram below.
Theca-lutein cysts replacing an ovary in a patient with a molar pregnancy. Despite their size these cysts are benign and usually resolve after treatment of the underlying disease.
Multiple functional cysts can occur as a result of excessive gonadotropin stimulation or sensitivity. In gestational trophoblastic neoplasia (hydatidiform mole and choriocarcinoma) and rarely in multiple and diabetic pregnancy, hCG causes a condition called hyperreactio luteinalis. In patients being treated for infertility, ovulation induction with gonadotropins (FSH and luteinizing hormone [LH]), and rarely clomiphene citrate, may lead to ovarian hyperstimulation syndrome, especially if accompanied by hCG administration.
Neoplastic cysts arise by inappropriate overgrowth of cells within the ovary and may be malignant or benign. Malignant neoplasms may arise from all ovarian cell types and tissues. By far, the most frequent are those arising from the surface epithelium (mesothelium), and most of these are partially cystic lesions. The benign counterparts of these cancers are serous and mucinous cystadenomas. Other malignant ovarian tumors may contain cystic areas, and these include granulosa cell tumors from sex cord stromal cells and germ cell tumors from primordial germ cells. A clear cell carcinoma is shown in the image below.
Cross-section of a clear cell carcinoma of the ovary. Note the cystic spaces intermingled with solid areas.
Teratomas are a form of germ cell tumor2 containing elements from all 3 embryonic germ layers, ie, ectoderm, endoderm, and mesoderm. A mature cystic teratoma is shown in the image below.
A dermoid cyst (mature cystic teratoma) after opening the abdomen. Note the yellowish color of the contents seen through the wall.
{{mediacaption:255941_3}}
Endometriomas are cysts filled with blood arising from the ectopic endometrium. In polycystic ovary syndrome, the ovary often contains multiple cystic follicles 2-5 mm in diameter as viewed on sonograms. The cysts themselves are never the main problem, and discussion of this disease is beyond the scope of this article.
Frequency
United States
Ovarian cysts are found on transvaginal sonograms in nearly all premenopausal women and in up to 18% of postmenopausal women.3 Most of these cysts are functional in nature and benign. Mature cystic teratomas or dermoids represent more than 10% of all ovarian neoplasms. The incidence of ovarian carcinoma is approximately 15 cases per 100,000 women per year. Annually in the United States, ovarian carcinomas are diagnosed in more than 21,000 women, causing an estimated 14,600 deaths.4 Most malignant ovarian tumors are epithelial ovarian cystadenocarcinomas. Tumors of low malignant potential comprise approximately 20% of malignant ovarian tumors, whereas fewer than 5% are malignant germ cell tumors, and approximately 2% granulosa cell tumors.
Mortality/Morbidity
- Benign cysts can cause pain and discomfort related to pressure on adjacent structures, torsion, rupture, hemorrhage (both within and outside of the cyst), and abnormal uterine bleeding. They rarely cause death. Mucinous cystadenomas may cause a relentless collection of mucinous fluid within the abdomen, known as pseudomyxoma peritonei, which may be fatal without extensive treatment.
- Mortality associated with malignant ovarian carcinoma is related to the stage at the time of diagnosis, and patients with ovarian carcinoma generally present late in the course of disease. The 5-year survival rate overall is 41.6%, varying between 86.9% for International Federation of Gynecology and Obstetrics (FIGO) stage Ia and 11.1% for stage IV.5 Granulosa cell tumors are associated with an 82% survival rate, whereas squamous cell carcinomas arising in a dermoid cyst have a very poor outcome. Most germ cell tumors are diagnosed at an early stage and have an excellent outcome. Advanced-stage dysgerminomas are associated with a better outcome compared to nondysgerminomatous germ cell tumors. A distinct group of less aggressive tumors of low malignant potential has a more benign course but is still associated with mortality.6 The overall survival rate is 86.2% at 5 years.
- Malignant ovarian cystic tumors can cause severe morbidity, including pain, abdominal distension, bowel obstruction, nausea, vomiting, early satiety, wasting, cachexia, indigestion, heartburn, abnormal uterine bleeding, deep venous thrombosis, and dyspnea. Cystic granulosa cell tumors may secrete estrogen, which leads to postmenopausal bleeding and precocious puberty in elderly patients and young patients, respectively.
Race
Malignant epithelial ovarian cystadenocarcinomas are the only ovarian cysts associated with racial differences.
- Women from northern and western Europe and North America are affected most frequently, whereas women from Asia, Africa, and Latin America are affected least frequently.
- Within the United States, age-adjusted incidence rates in surveillance areas are highest among American Indian women, followed by white, Vietnamese, Hispanic, and Hawaiian women. Incidence is lowest among Korean and Chinese women.7
- Among women for whom sufficient numbers of cases are available to calculate rates based on age, incidence in those aged 30-54 years is highest in white women, followed by Japanese, Hispanic, and Filipino women. For those aged 55-69 years, the highest rates occur in white women, followed by Hispanic and Japanese women. Among women aged 70 years or older, the highest rate occurs among white women, followed by those of African descent and Hispanic women.
Age
- Functional ovarian cysts occur at any age (including in utero), but are much more common in reproductive-aged women. They are rare after menopause. Luteal cysts occur after ovulation in reproductive-aged women. Most benign neoplastic cysts occur during the reproductive years, but the age range is wide and they may occur in persons of any age.
- The incidence of epithelial ovarian cystadenocarcinomas, sex cord stromal tumors, and mesenchymal tumors rises exponentially with age until the sixth decade of life, at which point the incidence plateaus. Tumors of low malignant potential occur at a mean age of 44 years, with a span from adolescence to senescence. The average age is more than a decade less than that for invasive cystadenocarcinoma. Germ cell tumors are most common in adolescence and rarely occur in those older than 30 years.
Clinical
History
- Most patients with ovarian cysts are asymptomatic but some cysts may be associated with a range of symptoms, sometimes severe.8 Even malignant ovarian cysts commonly do not cause symptoms until they reach an advanced stage.
- Pain or discomfort may occur in the lower abdomen. Torsion (twisting) or rupture may lead to more severe pain. An ovarian cyst that has undergone torsion is shown in the image below.
An ovarian cyst that has undergone torsion (twisting of the vascular pedicle). The patient presented with a short history of severe lower abdominal pain. The twisted pedicle can be seen attached to the cyst, which has turned dusky due to ischemia. No viable epithelial lining was available for histologic diagnosis.
- Patients may experience discomfort with intercourse, particularly deep penetration.
- Having bowel movements may be difficult, or pressure may develop, leading to a desire to defecate.
- Micturition may occur frequently and is due to pressure on the bladder.
- Irregularity of the menstrual cycle and abnormal vaginal bleeding may occur. Young children may present with precocious puberty and early onset of menarche.
- Patients may experience abdominal fullness and bloating.
- Patients may experience indigestion, heartburn, or early satiety.
- Endometriomas are associated with endometriosis, which causes a classic triad of painful and heavy periods and dyspareunia.
- Polycystic ovaries may be part of the polycystic ovary syndrome, which includes hirsutism, infertility, oligomenorrhea, obesity, and acne.
Physical
- Advanced malignant disease may be associated with cachexia and weight loss, lymphadenopathy in the neck, shortness of breath, and signs of pleural effusion.
- A large cyst may be palpable on abdominal examination. Gross ascites may interfere with palpation of an intra-abdominal mass.
- Although normal ovaries may be palpable during the pelvic examination in thin premenopausal patients, a palpable ovary should be considered abnormal in a postmenopausal woman. If a patient is obese, palpating cysts of any size may prove difficult.
- Sometimes, discerning the cystic nature of an ovarian cyst may be possible, and it may be tender to palpation. The cervix and uterus may be pushed to one side.
- Other masses may be palpable, including fibroids and nodules in the uterosacral ligament consistent with malignancy or endometriosis.
Causes
- Multiple functional cysts can occur as a result of excessive gonadotropin stimulation or sensitivity.
- In gestational trophoblastic neoplasia (hydatidiform mole and choriocarcinoma) and rarely in multiple or diabetic pregnancy, hCG is the stimulating gonadotropin. The condition is called hyperreactio luteinalis.
- Patients being treated for infertility by ovulation induction with gonadotropins or other agents, such as clomiphene citrate or letrozole, may develop cysts as part of ovarian hyperstimulation syndrome.
- Tamoxifen can cause benign functional ovarian cysts that usually resolve following discontinuation of treatment.
- Risk factors for ovarian cystadenocarcinoma include strong family history, advancing age, white race, infertility, nulliparity, a history of breast cancer, and BRCA gene mutations.
More on Ovarian Cysts |
 Overview: Ovarian Cysts |
| Differential Diagnoses & Workup: Ovarian Cysts |
| Treatment & Medication: Ovarian Cysts |
| Follow-up: Ovarian Cysts |
| Multimedia: Ovarian Cysts |
| References |
| Next Page » |
References
Clement PB. Anatomy and histology of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, NY: Springer-Verlag; 2002:649-673.
Caruso PA, Marsh MR, Minkowitz S, Karten G. An intense clinicopathologic study of 305 teratomas of the ovary. Cancer. Feb 1971;27(2):343-8. [Medline].
McDonald JM, Modesitt SC. The incidental postmenopausal adnexal mass. Clin Obstet Gynecol. Sep 2006;49(3):506-16. [Medline].
American Cancer Society. Cancer Facts and Figures 2009. Estimated New Cancer Cases and Deaths by Sex, US, 2009. American Cancer Society. Available at http://www.cancer.org/docroot/stt/stt_0.asp?from=fast. Accessed December 24, 2009.
International Federation of Gynecology and Obstetrics. Annual Report on the Results of Treatment in Gynaecological Cancer. J Epidemiol Biostat. 1998;3:1-68.
Sykes PH, Quinn MA, Rome RM. Ovarian tumors of low malignant potential: a retrospective study of 234 patients. Int J Gynecol Cancer. 1997;7:218-26.
Miller BA, Kolonel LN, Bernstein L, et al. Racial/Ethnic Patterns of Cancer in the United States 1988-1992. Bethesda, Md: National Cancer Institute; 1996.
Bottomley C, Bourne T. Diagnosis and management of ovarian cyst accidents. Best Pract Res Clin Obstet Gynaecol. Oct 2009;23(5):711-24. [Medline].
Jacobs I, Bast RC Jr. The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod. Jan 1989;4(1):1-12. [Medline].
Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. Feb 16 2002;359(9306):572-7. [Medline].
Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y. Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res. Feb 15 2008;14(4):1065-72. [Medline].
McIntosh M, Anderson G, Drescher C, Hanash S, Urban N, Brown P. Ovarian cancer early detection claims are biased. Clin Cancer Res. Nov 15 2008;14(22):7574; author reply 7577-9. [Medline].
Greene MH, Feng Z, Gail MH. The importance of test positive predictive value in ovarian cancer screening. Clin Cancer Res. Nov 15 2008;14(22):7574; author reply 7577-9. [Medline].
Osmers R. Sonographic evaluation of ovarian masses and its therapeutical implications [editorial]. Ultrasound Obstet Gynecol. Oct 1996;8(4):217-22. [Medline].
Loyer EM, Whitman GJ, Fenstermacher MJ. Imaging of ovarian carcinoma. Int J Gynecol Cancer. Sep 1999;9(5):351-361. [Medline].
Chan L, Lin WM, Uerpairojkit B, Hartman D, Reece EA, Helm W. Evaluation of adnexal masses using three-dimensional ultrasonographic technology: preliminary report. J Ultrasound Med. May 1997;16(5):349-54. [Medline].
Kupesic S, Plavsic BM. Early ovarian cancer: 3-D power Doppler. Abdom Imaging. Sep-Oct 2006;31(5):613-9. [Medline].
Higgins RV, Matkins JF, Marroum MC. Comparison of fine-needle aspiration cytologic findings of ovarian cysts with ovarian histologic findings. Am J Obstet Gynecol. Mar 1999;180(3 Pt 1):550-3. [Medline].
Moran O, Menczer J, Ben-Baruch G, et al. Cytologic examination of ovarian cyst fluid for the distinction between benign and malignant tumors. Obstet Gynecol. Sep 1993;82(3):444-6. [Medline].
Lu D, Davila RM, Pinto KR, Lu DW. ThinPrep evaluation of fluid samples aspirated from cystic ovarian masses. Diagn Cytopathol. May 2004;30(5):320-4. [Medline].
Roman LD. Small cystic pelvic masses in older women: is surgical removal necessary?. Gynecol Oncol. Apr 1998;69(1):1-2. [Medline].
Bailey CL, Ueland FR, Land GL, DePriest PD, Gallion HH, Kryscio RJ, et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol. Apr 1998;69(1):3-7. [Medline].
[Best Evidence] Grimes DA, Jones LB, Lopez LM, Schulz KF. Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev. Apr 15 2009;CD006134. [Medline].
Medeiros LR, Rosa DD, Bozzetti MC, Fachel JM, Furness S, Garry R, et al. Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database Syst Rev. Apr 15 2009;CD004751. [Medline].
Maiman M. Laparoscopic removal of the adnexal mass: the case for caution. Clin Obstet Gynecol. Jun 1995;38(2):370-9. [Medline].
Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet. Jan 20 2001;357(9251):176-82. [Medline].
Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, et al. Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol. Jan 2009;113(1):11-7. [Medline].
Eltabbakh GH, Charboneau AM, Eltabbakh NG. Laparoscopic surgery for large benign ovarian cysts. Gynecol Oncol. Jan 2008;108(1):72-6. [Medline].
Schmeler KM, Mayo-Smith WW, Peipert JF, et al. Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol. May 2005;105(5 Pt 1):1098-103. [Medline].
Further Reading
Keywords
ovarian cyst, ovarian cyst treatment, ovarian cyst causes, ovarian cyst symptoms, benign ovarian cyst, dermoid tumor, graafian follicles, functional cysts, theca-lutein cysts, hyperreactio luteinalis, ovarian hyperstimulation syndrome, serous cystadenoma, mucinous cystadenoma, granulosa cell tumor, sex cord stromal tumor, germ cell tumor, primordial cell tumor, teratoma, endometrioma, pseudomyxoma peritonei, ovarian tumors
gestational trophoblastic neoplasia, hydatidiform mole, choriocarcinoma, polycystic ovary syndrome, polycystic ovarian syndrome, PCOS, epithelial ovarian cystadenocarcinomas
